Clinical efficacy of ampicillin in treatment of acute odontogenic abscess;Klinička efikasnost ampicilina u lečenju akutnih dentogenih apscesa

Vojnosanitetski Pregled

Volumn 66, Issue 2, 2009, Pages 123-128

  Matijević, Stevo ^a   Lazić, Zoran ^a   Nonković, Zorka ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Ampicillin; Anti bacterial agents; Drug therapy; Oral surgical procedures; Periapical abscess

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT;

ABSCESS DRAINAGE; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; TOOTH ABSCESS; TOOTH EXTRACTION; ACUTE DISEASE; ADULT; BACTERIAL INFECTION; FEMALE; MALE; MICROBIOLOGY; TOOTH PERIAPICAL DISEASE;

ACUTE DISEASE; ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; FEMALE; HUMANS; MALE; PERIAPICAL ABSCESS;

EID: 63249105241     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP0902123M     Document Type: Article

References (32)

1. Gutiérrez-Pérez JL, Perea-Pérez EJ, Romero-Ruiz MM, Girón-González JA. Orofacial infections of odontogenic origin. Med Oral 2004; 9(4): 280-287 (English) (Spanish)
2. Bratton TA, Jackson DC, Nkungula-Howlett T, Williams CW, Bennett CR. Management of complex multi-space odontogenic infections. J Tenn Dent Assoc 2002; 82(3): 39-47.
3. Peterson LJ. Principles of management and prevention of odontogenic infections. In: Peterson LJ, Ellis E, Hupp JR, Tucker MR, editors. Contemporary Oral and Maxillofacial Surgery. 4ed. St. Louis: Mosby; 1998. p. 344-366
4. Lewis MA, McGowan DA, MacFarlane TW. Short-course high-dosage amoxycillin in the treatment of acute dento-alveolar abscess. Br Dent J 1986; 161(8): 299-302.
5. Martin MV, Longman LP, Hill JB, Hardy P. Acute dentoalveolar infections: an investigation of the duration of antibiotic therapy. Br Dent J 1997; 183(4): 135-137 (Pubitemid 127517814)
6. Fazakerley MW, McGowan P, Hardy P, Martin MV. A comparative study of cephradine, amoxycillin and phenoxymethylpenicillin in the treatment of acute dentoalveolar infection. Br Dent J 1993; 174(10): 359-363
7. von Konow L, Köndell PA, Nord CE, Heimdahl A. Clindamycin versus phenoxymethylpenicillin in the treatment of acute orofacial infections. Eur J Clin Microbiol Infect Dis 1992; 11(12): 1129-1135 (Pubitemid 23069061)
8. Gilmore WC, Jacobus NV, Gorbach SL, Doku HC, Tally FP. A prospective double-blind evaluation of penicillin versus clindamycin in the treatment of odontogenic infections. J Oral Maxillofac Surg 1988; 46(12): 1065-1070 (Pubitemid 19007815)
9. th ed. W.B. Saunders Company; 2002. p. 99-112.
10. Al-Belasy FA, Hairam AR. The efficacy of azithromycin in the treatment of acute infraorbital space infection. J Oral Maxillofac Surg 2003; 61(3): 310-316 (Pubitemid 36268377)
11. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N Engl J Med 1994; 330(17): 1247-1251 (Pubitemid 24122005)
12. Bischof WH. The use of systemic antibiotics in dental practice. Ann R Australas Coll Dent Surg 1998; 14: 62-65
13. Prostran M, Kažić T. Antibiotics-rational use. Belgrade: Section for clinical pharmacology DFJ; 1997. (Sebian)
14. th ed. Naučna knjiga, Belgrade; 1993. p. 91-130.
15. st ed. London: Royal Pharmaceutical Society; 1996.
16. Hancock RE. Peptide antibiotics. Lancet 1997; 349(9049): 418-422 (Pubitemid 27077684)
17. th ed. Reed Educational and Professional Publishing; 2002.
18. th ed. W.B. Saunders Company; 2002.
19. th ed. Philadelphia: W.B. Saunders Company; 2002. p. 99-111.
20. th ed. St. Louis: Mosby-Year Book; 1998. p. 496-533.
21. Feldmann G, Larje O. The bacterial flora of submucous abscesses originating from chronic exacerbating osteitis. Acta Odontol Scand 1966; 24(2): 129-145
22. Rega AJ, Aziz SR, Ziccardi VB. Microbiology and antibiotic sensitivities of head and neck space infections of odontogenic origin. J Oral Maxillofac Surg 2006; 64(9): 1377-1380 (Pubitemid 44205353)
23. Dirks SJ, Terezhalmy GT. The patient with an odontogenic infection. Quintessence Int 2004; 35(6): 482-502. (Pubitemid 38648585)
24. Brescó-Salinas M, Costa-Riu N, Berini-Aytés L, Gay-Escoda C. Antibiotic susceptibility of the bacteria causing odontogenic infections. Med Oral Patol Oral Cir Bucal 2006; 11(1): E70-5. (English) (Spanish)
25. Chan Y, Chan CH. Antibiotic resistance of pathogenic bacteria from odontogenic infections in Taiwan. J Microbiol Immunol Infect 2003; 36(2): 105-110 (Pubitemid 36850619)
26. Ashkenazi M, Ashkenazi S. Judicious use of antibiotics in dental practice. Refuat Hapeh Vehashinayim 2004; 21(4): 27-34, 94. (Hebrew)
27. Litterio M, Bianchini H, Carloni G, Di Martino A, Fernández Canigia L, Greco G, et al. "In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002. Rev Argent Microbiol 2004; 36(3): 130-135 (Spanish)
28. Eckert AW, Maurer P, Wilhelms D, Schubert J. Bacterial spectra and antibiotics in odontogenic infections. Renaissance of the penicillins? Mund Kiefer Gesichtschir 2005; 9(6): 377-383 (German)
29. Traub WH, Leonhard B. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 1997; 43(1): 10-20.
30. Traub WH, Leonhard B. Antibiotic susceptibility of alpha-and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs. Chemotherapy 1997; 43(2): 123-131 (Pubitemid 27099903)
31. Rozkiewicz D, Daniluk T, Sciepuk M, Zaremba ML, Cylwik-Rokicka D, Luczaj-Cepowicz E, et al. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population. Adv Med Sci 2006; 51 Suppl 1: 191-195
32. Limeres J, Tomás I, Alvarez M, Diz P. Empirical antimicrobial therapy for odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100(3): 263-264